Artelo Biosciences (ARTL) Shares Outstanding (Entity) (2014 - 2024)
Powered by 
Analysis
Artelo Biosciences (ARTL) Shares Outstanding (Entity) (2014 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 722.67 Mn |
| 10 | Artelo Biosciences | 120,353.04 | -479,646.96 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 19,924.00 |
| Mar 31, 2024 | 19,924.00 |
| Dec 31, 2023 | 19,685.00 |
| Sep 30, 2023 | 19,521.00 |
| Jun 30, 2023 | 17,628.00 |
| Mar 31, 2023 | 17,628.00 |
| Dec 31, 2022 | 17,628.00 |
| Sep 30, 2022 | 17,628.00 |
| Jun 30, 2022 | 17,530.00 |
| Mar 31, 2022 | 17,409.00 |
| Nov 30, 2021 | 12.53 Mn |
| Aug 31, 2021 | 7,685.00 |
| May 31, 2021 | 9,527.00 |
| Feb 28, 2021 | 6,991.00 |
| Nov 30, 2020 | 4,205.00 |
| Aug 31, 2020 | 1,526.00 |
| May 31, 2020 | 1,537.00 |
| Feb 29, 2020 | 1,411.00 |
| Nov 30, 2019 | 1,410.00 |
| Aug 31, 2019 | 894.00 |